Trilexium | MedChemExpress (MCE)

Trilexium (TRX-E-009-1) is a third-generation of benzopyran structurally related to TRX-E-002-1 (HY-114250). Trilexium increases p21 protein expression and induces apoptosis. Trilexium depolymerizes microtubules. Trilexium shows broad anti-cancer activity[1][2].

Trivial name Trilexium
Catalog Number HY-157800
Alternative Name(s) TRX-E-009-1
Research Area Cancer
CAS# 1983180-82-0
Purity 99.7%
SMILES OC1=C(OC)C=C([C@H]2[C@@H](C3=CC(F)=C(C=C3)O)C4=CC=C(O)C(C)=C4OC2)C=C1OC
Size 5 mg
Supplier Page https://www.medchemexpress.com/trilexium.html